Rheumatologists, general practictioners discuss ways to improve their connection, remove barriers to patient care
Drugs Studied for Use in Rheumatoid Arthritis, Weight Loss
Plus, rheumatology drug news from EULAR 2014
EULAR 2014: Research on Rheumatoid Arthritis, Spondyloarthritis
Latest findings on rheumatological drug therapies, including methotrexate for RA, tumor necrosis factor inhibitors for SpA
Spondyloarthritis: Clues to Earlier Recognition
Rheumatologists at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting discuss challenges to diagnosing, managing spondyloarthritides
Letters: UCLA Study on HLA-B27 Link with Ankylosing Spondylitis at Forefront
Researchers Scholosstein et al were first to connection HLA antigens to the inflammatory disease, not Brewerton et al as reported [The Rheumatologist, May 2014]
Practicing Rheumatology in Dubai
Rheumatologist Humeira Badsha, MD, describes caring for rheumatology patients in the United Arab Emirates, launching the Emirates Arthritis Foundation
7 Things Ophthalmologists Want Rheumatologists to Know
Careful collaboration is key to treating patients with rheumatic or inflammatory diseases that affect the eyes
Rheuminations: Ankylosing Spondylitis Sometimes Defies Detection
How method of diagnosing, treating this inflammatory back disease characterized by stiffness and the presence of HLA-B27 gene has evolved
Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis
New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation
Treating Early-Stage Spondyloarthritis May Prevent Disease Progression, Say Researchers at the ACR/ARHP Winter Rheumatology Symposium
Therapy with tumor necrosis factor inhibitors, nonsteroidal antiinflammatory drugs, ustekinumab in early stages of osteitis may halt molecular switching to bone-forming phenotype characteristic of SpA
- « Previous Page
- 1
- …
- 5
- 6
- 7
- 8
- 9
- 10
- Next Page »